The use of robot-assisted surgery for treatment of genitourinary malignancies is increasing dramatically. Kaye and colleagues argue that consumerism, rather than surgical outcomes, drives the adoption of this expensive technology. Robotics use should be targeted to surgical situations where clinical benefit or cost-effectiveness can be demonstrated.
- Deborah R. Kaye
- Jeffrey K. Mullins
- Trinity J. Bivalacqua
